Ankara City Hospital Bilkent
saglik.gov.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
416
Active
93
Phase 3
1
Total enrollment
60,023
Pipeline matrix
Showing 20 of 20 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Umbilical Cord-Derived Mesenchymal Stem Cells | — | — | — | — | — | 1 | |
| Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes | — | — | — | — | — | 1 | |
| Remifentanil | — | — | — | — | — | 2 | |
| Ephedrine | — | — | — | — | — | 1 | |
| Noradrenalin | — | — | — | — | — | 1 | |
| 5% dextrose | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | — | 1 | |
| Rocuronium | — | — | — | — | — | 1 | |
| Lidocaine and Dexamethasone for PENG Block | — | — | — | — | — | 1 | |
| Dutasteride | — | — | — | — | — | 1 | |
| Lidocaine spray | — | — | — | — | — | 1 | |
| Bupivacain | — | — | — | — | — | 1 | |
| Etofenamat | — | — | — | — | — | 1 | |
| Diclofenac | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| Normal Saline | — | — | — | — | — | 1 | |
| Rhomboid Intercostal Block | — | — | — | — | — | 1 | |
| Serratus Posterior Superior Intercostal Plane Block | — | — | — | — | — | 1 | |
| moderate dose Dexamethasone | — | — | — | — | — | 1 | |
| High dose dexamethasone | — | — | — | — | — | 1 |
Next readouts
- 2023-07-01
- 2024-05-01
- 2024-10-01
- 2024-12-01
- 2026-04-01
- 2026-04-23
- 2026-05-30
- 2026-07-30
- 2026-10-01
- 2026-10-01
Top conditions
- Anesthesia18
- Postoperative Pain10
- Sedation7
- Pain, Postoperative7
- Cardiac Surgery6
- Anxiety5
- Knee Osteoarthritis5
- Sarcopenia5
Frequently asked questions about Ankara City Hospital Bilkent
- How many clinical trials does Ankara City Hospital Bilkent have on ClinicalTrials.gov?
- Ankara City Hospital Bilkent is listed as the lead sponsor on 416 clinical trials in ClinicalTrials.gov, 93 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ankara City Hospital Bilkent's trials are in Phase 3?
- 1 of Ankara City Hospital Bilkent's trials are in Phase 3, spread across 20 active drug programs.
- What therapeutic areas does Ankara City Hospital Bilkent focus on?
- Ankara City Hospital Bilkent's most-studied conditions on ClinicalTrials.gov are Anesthesia, Postoperative Pain, Sedation, Pain, Postoperative, Cardiac Surgery.
- When are Ankara City Hospital Bilkent's next clinical trial readouts?
- Ankara City Hospital Bilkent has 10 upcoming primary-completion readouts tracked here; the soonest is “Lidocaine Spray Use on Patients Comfort in Undergoing Bladder Catheterization”, expected around 2023-07-01.